...
首页> 外文期刊>Diabetes technology & therapeutics >A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors
【24h】

A Novel and Easy Method to Locate and Remove First Approved Long-Term Implantable Glucose Sensors

机译:一种新颖简便的方法来定位和去除第一批准的长期可植入葡萄糖传感器

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Eversense is a long-term implantable continuous glucose monitoring (CGM) system. Difficulty in locating and removing implanted sensors is one of the issues limiting its use. We propose using near-infrared (NIR) light to locate implanted glucose sensors. NIR light was used to locate implanted glucose sensors in 30 patients (age 18-62 years) with type 1 diabetes who use Eversense sensors for CGM. Duration of sensor implantation was 10-40 weeks (median 12 weeks). Out of 30 patients with type 1 diabetes, the NIR light located the implanted sensor in 24 patients (success rate 80%) within 5 s. Sensor implantation at the skin with tattoos and excessive freckles were two main reasons for failure to locate sensors using NIR. We report an innovative method to locate implanted glucose sensors in seconds, which would reduce the time significantly to remove the sensor.
机译:Eversense是一种长期可植入的连续葡萄糖监测(CGM)系统。 定位和删除植入传感器的难度是限制其使用的问题之一。 我们建议使用近红外(NIR)光来定位植入的葡萄糖传感器。 NIR光用于在30名患者(18-62岁)中定位植入的葡萄糖传感器,其中1型糖尿病用于CGM的Eversense传感器。 传感器植入的持续时间为10-40周(12周中中值)。 除了30型糖尿病患者中,NIR光位于24名患者的植入传感器(成功率80%)。 用纹身和过度雀斑的皮肤上的传感器植入是使用NIR定位传感器的两个主要原因。 我们报告了一种创新方法,以便在几秒钟内定位植入的葡萄糖传感器,这将减少显着的时间以删除传感器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号